Amrize Ltd AMRZ
38.22
0.99
2.66%
as of 25 Sep
- Market cap
- $20.5B
- P/E
- 17.5×
Follow AMRZ
Insider Buys
alert about insiders buying in the last 12 month
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
P/E ratio |
20.01 | 20.01 | 25.12 |
P/S ratio |
0.00 | 0.00 | 2.53 |
P/FCF ratio |
43.05 | 43.05 | 20.47 |
P/Operating CF |
(33.59) | (33.59) | 16.58 |
P/B ratio |
2.90 | 2.90 | 2.28 |
Price to Tangible BV |
2.90 | 2.90 | 12.73 |
EV/Sales |
0.00 | 0.00 | 2.82 |
EV/EBITDA |
0.00 | 0.00 | 11.79 |
EV/Operating CF |
19.84 | 19.84 | 15.06 |
EV/FCF |
42.34 | 42.34 | 22.76 |
Quick Ratio |
1.03 | 1.25 | 1.06 |
Current Ratio |
1.61 | 1.87 | 1.64 |
Net Debt/EBITDA |
0.00 | (0.16) | 1.19 |
Debt/Assets |
4.80% | 4.68% | 21.73% |
Debt/Equity |
0.12 | 0.11 | 0.40 |
Asset Turnover |
0.00 | 0.50 | 0.49 |
Operating CF/Net income |
2.13 | 1.79 | 1.86 |
Capex/Depreciation |
(0.68) | (0.62) | (0.82) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 0.00% | 13.33% | 10.23% | |
| 0.00% | 5.44% | 4.93% | |
ROIC |
12.71% | 14.07% | 7.18% |
Return on Tangible Assets |
10.49% | 13.05% | 12.14% |
Average Days of Receivables |
43.70 | 49.93 | 34.60 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
7.69% | 8.07% | 9.55% |
Intangible Assets out of Total Assets |
0.47 | 0.45 | 0.44 |
Share Based Compensation of Revenue |
0.04% | 0.05% | 0.12% |
Graham Net Nets |
0.17 | 0.17 | (0.22) |
Graham Number |
0.00 | 0.00 | 33.90 |
Earnings Yield |
5.00% | 5.00% | 3.98% |
Free Cash Flow Yield |
2.32% | 2.32% | 4.88% |
Revenue per Share |
0.00 | 21.16 | 21.36 |
Operating CF per Share |
0.00 | 4.13 | 3.99 |
Capex per Share |
0.00 | (0.99) | (1.35) |
Free Cash Flow per Share |
0.00 | 3.13 | 2.64 |
Cash per Share |
0.00 | 2.87 | 3.48 |
Shareholders Equity per Share |
0.00 | 17.92 | 23.96 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 17.92 | 23.96 |
Free Cash Flow |
1,455.00 | 1,733.00 | 1,461.00 |
Working Capital |
1,496.00 | 2,231.00 | 1,824.00 |
Capital Expenditures |
(581.00) | (549.00) | (747.00) |
Net Current Asset Value |
(9,905.00) | (9,110.00) | (6,314.00) |
EV/EBIT |
0.00 | 0.00 | 17.45 |
Capex to Sales |
0.05 | 0.05 | 0.06 |
Net Profit Margin |
8.19% | 10.89% | 10.03% |
Price to Operating Income |
0.00 | 0.00 | 15.69 |
| Other line items | |||
Depreciation/Fixed assets |
0.11 | 0.12 | 0.12 |
Cash ROIC |
(48.91%) | (41.64%) | (28.01%) |
Accounts Receivable Turnover |
0.00 | 7.81 | 8.68 |
Accounts Payable Turnover |
0.00 | 6.82 | 6.22 |
Inventory Turnover |
0.00 | 6.26 | 5.85 |
Average Days of Payables |
51.14 | 54.32 | 63.93 |
Days of Inventory on Hand |
53.55 | 61.38 | 64.47 |
Average Receivables |
— | 1,499.50 | 1,360.50 |
Average Payables |
— | 1,266.50 | 1,411.50 |
Average Inventory |
— | 1,379.50 | 1,501.50 |
Average Assets |
— | 23,426.00 | 24,027.00 |
Average Common Equity |
— | 9,558.50 | 11,584.00 |
Columns are period end dates